Car T Cell Therapy Nature Review
However resistance often occurs.
Car t cell therapy nature review. Cd19 targeted chimeric antigen receptor car t cells induce high complete response rates in paediatric b cell acute lymphoblastic leukaemia b all cases but many of these patients will relapse. A preclinical study recently identified another target antigen gprc5d with comparable efficacy and toxicity to bcma targeted car t cell therapy 183. One of the most promising approaches in cancer treatment is chimeric antigen receptor car t cell therapy in which part of the body s own immunological defendors t cells are redirected against cancerous cells after being engineered to express cars. Key points chimeric antigen receptor car t cell immunotherapy is a highly effective form of adoptive cell therapy as demonstrated by the remission rates in patients with b cell acute.